2023-05-31 21:31:17
health
It is the first medication that acts preventively for this condition, which affects 52 percent of the world’s population each year.
31/5/2023
Many of the ten million migraine sufferers in the UK will go to bed easier today knowing that the NHS, the state health service, He will begin to distribute some pills that prevent his illness.
This was revealed by the country’s main newspaper, The Times, which also ensures that Medicine changes the lives of these patients.
The active substance of the medicine is called Rimegepant and It was approved by the institution that regulates drugs in the country, the National Institute for Health and Care Excellence (Nice).
Some 145,000 people, the entity said, are candidates to use the pills, only in England.
It is just one of the new medicines for this condition that you plan to include the NHS in your health plan, which is currently going through a serious crisis.
The medicine, the Times continued, is not taken with water, but rather it is allowed to dissolve under the tongue.
Its accumulation in that organ inflames blood vessels interconnected with nerves, which triggers migraine attacks, I explain the note from The Times.
Solo those who present 4 to 15 episodes per month They will deserve the treatment. Another condition is that none of the medicines available on the market have served them.
Ultimately, the important thing for patients is to know that the drug halves the frequency of moderate to severe headaches.
In addition, It is effective if consumed minutes following the pain appears, assured the Times.
Thus, its innovation is that It is the first option that acts preventively, since the usual until now was to relieve the symptoms with pain pills, which help to interrupt the signs of this phenomenon.
The leader of the investigation that concluded with the invention of this medication was Dr. Peter Goadsby, who corroborated the newspaper that migraine it is a neurological disorder that can be disabling. Women, he pointed out, are more prone to suffer from it.
In addition, he described the decision to start distributing the medicine in the country as an “important advance” for those who have not found a cure in other alternatives.
Actually, there are other preventive medicines for this disease, which work in a similar way to Vydura, but offer a drawback and that is that given as a monthly injection which is less convenient, according to specialists.
The Norwegian University of Science and Technology undertook the task of reviewing more than 350 studies on the subject between 1960 and 2020.
The investigation found that 52 percent of the world population has suffered an episode of headache at least once a year.
1685569494
#launch #miraculous #drug #lives #migraine #patients